The leucine-rich repeat receptor kinase (LRR-RK) BRI1 requires a shape-complementary SERK co-receptor for brassinosteroid sensing and receptor activation. Interface mutations that weaken the interaction between receptor and co-receptor in vitro reduce brassinosteroid signaling responses.
mutant SERK3 ectodomains cannot rationalize their gain-of-function phenotype in planta ( Fig. 1bd ).
Recently, the BRI1-ASSOCIATED-KINASE1 INTERACTING KINASE 3 (BIR3) has been reported as a negative regulator of BR signaling in Arabidopsis 17 . Ectopic overexpression of BIR3 results in BR loss-of-function phenotypes including BL insensitivity and reduced BRI1-EMS-SUPPRESSOR 1 (BES1) dephosphorylation 17 . The cytosolic pseudokinase domains of BIR2 and BIR3 bind the SERK3 kinase domain in yeast-2-hybrid assays and the full-length proteins interact in planta 17, 18 . We hypothesized that also the highly conserved BIR ectodomains may contribute to BIR3 -SERK3 complex formation. Indeed, we found that the recombinantly purified BIR3 LRR domain binds SERK3 with a K D of ~1 μM and with 1:1 stoichiometry (N) in isothermal titration calorimetry (ITC) experiments ( Fig. 2a ). No binding was detected between the BIR3 and BRI1 ectodomains ( Fig. 2a ). While BIR3 and BIR2 cannot discriminate between different SERK ectodomains in vitro (K D ranges from ~1 to ~3 μM), bir3 but not bir2-1 or bir2-3 mutant plants display a weak BR gain-of-function signaling phenotype (Figs. 2a-c, S1,S3, Table S1 ). SERK -BIR complex formation is likely driven by their extracellular LRR domains, as we could not observe detectable binding of the cytoplasmic (pseudo)kinase domains in ITC assays (Fig. S2) .
We next tested, if the elg mutation could modulate the interaction between BIRs and SERK3.
Indeed, the SERK3 D122N mutant shows ~4-fold reduced binding to BIR3 and ~8-fold reduced binding to BIR2 ( Fig. 2a,b ). Due to its low expression yield, the SERK3 D122A mutant (Fig. 1 ) could not be assayed by ITC. Together, our experiments suggest that SERK3 D122 maps to the interface of different SERK3 -BIR complexes and that interactions between interface residues may be compromised in the elg mutant background.
To gain insight into the BIR targeting mechanism, we sought to determine a crystal structure of BIR3 but did not succeed in obtaining diffraction quality crystals. Crystals of the related BIR2 ectodomain (residues 29-221, ~60% sequence identity with BIR3) diffracted to 1.9 Å resolution (Table S2 ). BIR2 contains five LRRs and shows a high degree of structural conservation with SERKs (r.m.s.d is ~1.5 Å comparing 175 corresponding C α atoms in BIR2 and SERK1) with the exception of a protruding loop in the N-terminal capping domain of BIR2 (magenta in Fig. 3a) . The BIR2 N-and C-terminal caps as well as the LRR core are stabilized by disulfide bridges conserved among the different BIR family members (Figs. 3c, S4 ). The conserved Asn58 in the BIR2 N-cap is glycosylated in our structure (Fig. 3c, S4) . A set of solvent exposed hydrophobic residues including BIR2 W73 from the protruding loop, BIR2 F128 , BIR2 F152 and BIR2 R176 form a lateral surface patch conserved among BIRs from different species, but not in SERK proteins (Figs. 3b,c, S4 ). This potential interaction surface differs from the central binding platform used by SERKs for targeting ligand-sensing LRR-RKs ( Fig. 3c) 9, 10 . We generated several point-mutations in the respective surface areas and assayed the mutant proteins vs. SERK3 in ITC assays. BIR2 E84R and BIR2 V157D originating from the central LRR groove still bind SERK3, suggesting that this interaction platform is not used by BIRs to target SERKs (Figs. 3c,d ). Mutation of BIR2 W73 from the protruding N-cap loop to alanine weakens the interaction with SERK3 and replacing BIR2 F152 or BIR2 R176 from the lateral surface patch with alanine disrupts binding ( Figs. 3c,d) . Thus, the unique N-cap loop and the lateral surface patch in the LRR domain of BIR2 are involved in the interaction with SERK3.
To understand how BIRs target the central, elg-containing surface in SERKs, we performed crystallization trials for various BIR -SERK ectodomain combinations. We obtained crystals for a BIR3 -SERK1 complex diffracting to 1.25 Å resolution (Table S2 ). Our crystals contain a fully glycosylated BIR3 -SERK1 heterodimer in the asymmetric unit, consistent with their in solution behavior (Figs. 4a, S5). Most surface areas of the SERK1 LRR domain are shielded by carbohydrate, except for the central interaction surface used to, for example, bind the BRI1 and HAESA ligand-sensing LRR-RKs 3, 5, 10, 19 . Structural comparison of the BIR3 -SERK1 complex with structures of the isolated SERK1 and BIR2 ectodomains reveals no major conformational rearrangements in BIRs and SERKs upon complex formation, with the exception of the protruding loop containing BIR2 W73 or the corresponding Trp67 in BIR3 (Fig. S6 ). In the complex structure, BIR3 establishes a network of hydrophobic and polar interactions with the SERK1 C-terminal cap and with the two C-terminal LRRs (total buried complex surface area is ~1,400 Å 2 ) ( Fig. 4a ).
Several polar contacts are mediated by water molecules. The complex structure reveals the tip of the BIR3 protruding N-cap loop in direct contact with the SERK1 elg surface (Fig. 4b ). SERK residues Asp122 (numbering corresponds to SERK3 throughout) and the neighboring Tyr124 together coordinate a water molecule, which in turn hydrogen bonds with BIR3 E69 in the protruding loop tip ( Fig. 4b ). The neighboring Tyr100 establishes an additional hydrogen bond with BIR3 E69 and the remaining loop tip residues BIR3 N68 and BIR3 K70 form similar interaction with SERK residues Asn148 and Asn77, respectively ( Fig. 4b ). Importantly, mutation of SERK Tyr100 or Tyr124 to alanine reduces BIR2 binding ( Fig. 4b,d ). Both tyrosine residues are also part of the BRI1 -SERK complex interface and, importantly, mutation of SERK3 Y100 but not SERK3 Y124 to alanine weakens the interaction with BRI1 ( Fig. 4e ).
An additional set of hydrophobic contacts involving BIR3 W67 (corresponds to BIR2 W73 analyzed in Fig. 3c,d ), BIR3 I75 , BIR3 Y122 , BIR3 V124 and BIR3 F146 (corresponds to BIR2 F152 , see Fig. 3c ,d) and SERK residues Val168, Ile192, Pro191 are dominating the interactions between the BIR3 and SERK1 C-terminal halves (Fig. 4a,c) . BIR3 R170 , the corresponding mutation in BIR2 R176 to alanine disrupts complex formation with SERK3 ( Fig. 3d ), forms hydrogen bonds with backbone atoms in the SERK1 C-cap and other polar contacts are mediated by water molecules (Fig. 4c ). Taken together, BIR3 targets the central LRR surface of SERKs normally used for the interaction with ligand-sensing LRR-RKs. The unique protruding loop in BIRs directly contacts the elg surface patch, rationalizing the reduced binding of SERK3 D122N to BIR ectodomains in vitro ( Fig. 2a,b ).
We next tested if the SERK -BIR LRR domain complex interface controls association of the fulllength proteins in planta. We found that wild-type SERK3 associated with BIR3 in coimmunoprecipitation experiments (Fig. 4f ), as shown previously 17 . The SERK3 D122N , SERK3 D122A , SERK3 Y100A , SERK3 Y124A mutants, all of which show reduced binding to isolated BIR LRR domains in vitro, consistently show reduced interaction with BIR3 in vivo ( Fig. 4f ). SERK3 F60 lies outside the SERK -BIR complex interface, but forms part of the BRI1 -SERK steroid binding pocket 5, 6 and its mutation to alanine disrupts BR complex formation in vitro and in planta 10 . Consistent with our BIR targeting model, the SERK3 F60A mutant shows wild-type binding to BIRs in ITC assays and retains interaction with BIR3 in vivo ( Fig. 4d ,f).
Our biochemical observation that SERKs can form tight heterodimeric complexes with BRI1 or
with BIRs using largely overlapping interaction surfaces ( Fig. S7 ), prompted us to investigate if the BRI1 and BIR ectodomains could compete for SERK binding. We performed analytical sizeexclusion chromatography experiments with the isolated BRI1, SERK3 and BIR2 LRR domains and in the pre-or ab-sence of the steroid hormone. In our ITC assay ( Fig. 2a ), we could not detect complex formation between BRI1 and BIR3, and consistently BIR2 was unable to dissociate an already formed BRI1-BL-SERK3 complex ( Fig. 4g ). However, BIR2 could efficiently compete with BRI1 for SERK3 binding (Fig. 4g ), in line with our observation that the experimentally determined stoichiometries, binding affinities and -kinetics for the different complexes are similar (Figs. 1d, 2a).
Taken together, the molecular characterization of the SERK3 elg allele has revealed that the BR signaling pathway is under negative regulation by the ectodomain of BIR3. We show that SERK3 D122N disrupts BIR but not BRI1 binding and thus exhibits a gain-of-function phenotype (Figs. 1c, 2b) . Mutation of the neighboring SERK3 Y100 and SERK3 Y124 to alanine strongly decreases BIR binding, but only SERK3 Y124A retains the ability to bind BRI1 -BL with high affinity (Figs. 4df). Consistently, SERK3 Y124A , but not SERK3 Y100A or SERK3 Y100A/Y124A displays a statistically significant gain-of-function phenotype in hypocotyl growth assays ( Fig. 1b,c) . The BR-specific nature of the elg allele may thus be related to its ability to bind BRI1, but not other SERK3dependent LRR-RKs with high affinity 12 . The elg and bir3 phenotypes and our quantitative biochemical assays reveal that BRI1 and BIRs can compete for binding to SERKs, with BRI1 being able to out-compete BIRs in the presence of BL. We speculate that this negative regulation of SERKs by BIR proteins may allow for sharper signal transitions, with signaling competent BR complexes forming only in response to significant changes in BR concentration. Specific physiological functions have been genetically assigned to the different BIR family members in Arabidopsis: BIR1, a catalytically active protein kinase, specifically inhibits SERK3 co-receptor function in immunity and cell death, with bir1 loss-of-function mutants showing constitutive defense responses associated with a severe growth phenotype [20] [21] [22] . BIR2 and BIR3 are additional SERK3 interactors and both proteins are pseudokinases 17, 18, 23 . Different bir2 knock-down lines show altered immune responses but no BR signaling phenotype, while bir3 loss-and gain-of function mutants affect BR signaling ( Fig. 2c) 17, 18 . We cannot rationalize these specific functions of the different BIRs at the biochemical level, as all BIR ectodomains tested bind various SERK proteins with similar dissociation constants ( Fig. 2a ), in agreement with a recent study on the role of BIR1 in FLS2-mediated immune signaling 22 . This behavior of BIR proteins is reminiscent of SERKs, which also are largely promiscuous at the biochemical level, but which show partly specific, partly overlapping functions in plant growth, development and immunity 9 . While BIR ectodomains and not their cytosolic kinase domains allow for high affinity SERK binding (Figs. 2-4, S2), BIR signaling specificity may be encoded in their cytosolic domains, as seen with ligandsensing LRR-RKs 10, 24 . In line with this, specific BIR adapter proteins have been reported 25, 26 , which could allow for the targeting of BIR family members to specific membrane (nano)-domains 27 , and which could help to create specific signaling outputs in the cytosol 25 . The fact that the bir3-2 mutant does not phenocopy elg plants (Figs. 1b, 2c), suggests that other negative regulators of BR signaling complexes remain to be discovered in the future.
Methods

Plant material and growth conditions
Genomic SERK3 was amplified from Arabidopsis thaliana (ecotype Col-0), cloned into pDONR221 (ThermoFisher Scientific) and mutations were introduced by site directed mutagenesis (TableS3). Constructs were assembled employing multi-site Gateway technology into the binary vector pH7m34GW (ThermoFisher Scientific), introduced in the Agrobacterium tumefaciens strain pGV2260, and transformed into Arabidopsis using the floral dip method 28 
Hypocotyl growth assay
After surface sterilization with 70 % ethanol, 0.1 % Triton X-100 for 20 min and stratification at 4°C for 2 days, seeds were plated on ½ MS, 0.8 % agar plates supplemented with either 1 μM brassinazole (BRZ, from a 10 mM stock solution in 100 % DMSO, Tokyo Chemical Industry Co. LTD) or, for the controls, with 0.1 % (v/v) DMSO. After light exposure for 1 h, plates were incubated at 22 °C for 5 d in the dark and subsequently scanned at 600 dpi on a regular flatbed scanner (CanoScan 9000F, Canon). Measurements were taken using FIJI 29 and analyzed with the packages mratios 30 and multcomp 31 as implemented in R 32 (version 3.3.2). We report unadjusted 95% confidence limits for fold-changes instead of p-values 33 . Log-transformed endpoint hypocotyl lengths were analyzed employing a mixed effects model for the ratio of of a given line 'to the wildtype Col-0 allowing heterogeneous variances. To evaluate the treatment-by-mutant interaction, the 95 % two-sided confidence intervals for the relative inhibition (Col-0: untreated vs. BRZ-treated hypocotyl length)/(any genotype: untreated vs. BRZ-treated hypocotyl length) was calculated for the log-transformed length. Hypocotyl growth assays were performed three times, with similar results. 
Protein expression and purification
Grating coupled interferometry (GCI)
The Creoptix WAVE system (Creoptix AG, Switzerland), a label-free surface biosensor 35 
Crystallographic structure solution and refinement
The BIR2 anomalous dataset was used for experimental phasing using the Single Anomalous Diffraction (SAD) method. Ten consistent sulfur sites were identified using ShelxD 37 and Phenix.hyss 38 and used for site refinement and phasing in Sharp 39 (Table S2 ). Density modification, 2-fold NCS averaging and phase extension to 1.9 Å in the program Phenix.resolve 40 yielded a readily interpretable electron density map and the structure was completed in alternating cycles of manual building/rebuilding in Coot 41 , and restrained TLS refinement in Refmac5 42 .
The structure of the BIR3 -SERK1 complex was solved using the molecular replacement method as implemented in the program Phaser 43 , and using the isolated BIR2 and SERK1 (PDB-ID 4LSC 5 ) structures as search models. The solution comprises a hetero-dimer in the asymmetric unit and the structure was completed by manual correction in Coot and anisotropic refinement in Refmac5.
The quality of the refined structures were assessed using the program Molprobity 44 , structural diagrams were made with Pymol (https://sourceforge.net/projects/pymol/) and Chimera 45 .
Analytical size exclusion chromatography
Gel filtration experiments were performed using a Superdex 200 Increase 10/300 GL column (GE Healthcare) pre-equilibrated in either 20 mM sodium citrate pH 5.0, 150 mM NaCl for LRR domain interaction assays, or with 20 mM Hepes pH 7.5, 150 mM NaCl, 1 mM MgCl 2 , 0.5 mM TCEP for cytplasmic domain oligomeric state analysis. 500 μl of the respective protein (0.2 mg/mL) was loaded sequentially onto the column and elution at 0.75 ml/min was monitored by ultraviolet absorbance at 280 nm. BL concentration was 1 μM in the BRI1 -BL -SERK3 complex sample prior to loading.
Plant protein extraction and immunoprecipitation
Surface-sterilized and stratified seeds were plated on ½ MS, 0.8 % agar plates and grown for ~14 d. extraction buffer at 95 °C. Samples were separated on 10 % SDS-PAGE gels; In the subsequent western blots SERK3:6HA was detected using anti-HA antibody coupled to horse radish peroxidase (HRP, Miltenyi Biotec) at 1:5,000 dilution, while BIR3 was detected using a polyclonal BIR3 antibody 17 at 1:500 dilution followed a secondary anti-rabbit HRP antibody (1:10,000, Calbiochem #401353). Co-immunoprecipitation experiments were repeated two times, with similar outcome. c, Hypocotyl growth assay in the pre-and absence of BRZ (compare Fig. 1b ). Relative inhibition together with upper and lower confidence intervals are shown alongside; Col-0 and serk1-1 serk3-1 are the same as shown in Fig. 1b (N=5, n=50) . Fig. S1 : Hypocotyl growth assay raw data.
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Figure legends
Supplemental Figures
Shown are box plots with the raw data depicted as individual dots. Untreated: black, BRZ treated: blue, N=5, n=50. The void (v 0 ) volume is shown, together with elution volumes for molecular mass standards (Ov, reveals that all isolated cytoplasmic domains behave as apparent monomers in solution. The void (v0) volume is shown, together with elution volumes for molecular mass standards (Ov, Ovalbumin, 44,000 Da; CA, Carbonic anhydrase, 29,000 Da). d, Isothermal titration calorimetry (ITC) experiments with cytoplasmic domains of SERK3 vs. BIR2 (left) and BRI1 (right). No binding was detected, suggesting that the binding affinity between BIR2 and SERK3 or BRI1 and SERK3 is relatively low. Thus, BIR binding may be driven by their extracellular, rather than by their cytoplasmic domains. 
